Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/22 → 12/13/23 |
Funding
- PPD Investigator Services LLC: $11,325.00
ARGX-113-1902: Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Subcutaneously Administered Efgartigimod with rHuPH20 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CID
- Mahuwala, Zabeen (PI)